AgaMatrix (Salem, NH) maker of blood glucose monitoring systems that provide results to help users better manage their diabetes closed a $23.7M Series C financing. Participants include Ferrer Freeman & Co.
AgaMatrix, Inc.: Series C $23.7M
January 20, 2008
Leave a Comment » | 
I - Series C, Q - 1Q08, R - NORTH EAST, X - Device (Diabetes) | 
Permalink
Posted by arubenstein
